Liu Hui, Yao Jie, Wang Weijing, Zhang Dongfeng
Department of Epidemiology and Health Statistics, Qingdao University Medical College, Qingdao, China.
J Clin Hypertens (Greenwich). 2017 Oct;19(10):1032-1041. doi: 10.1111/jch.13042. Epub 2017 Jun 13.
A meta-analysis was conducted to evaluate the association between duration of oral contraceptive use and risk of hypertension. Relevant studies published in English or Chinese were identified by a search of PubMed, Web of Science, Wanfang Database, and China National Knowledge Infrastructure to January 2017. Seventeen articles containing 24 studies with 270,284 participants were included in this meta-analysis. The pooled relative risk of hypertension for the highest vs lowest category of oral contraceptive duration was 1.47 (95% confidence interval, 1.25-1.73), and excluding three studies with a relative risk >3.0 yielded a pooled relative risk of 1.26 (95% confidence interval, 1.11-1.44). A linear dose-response relationship was found (P =0.69) and the risk of hypertension increased by 13% (relative risk, 1.13; 95% confidence interval, 1.03-1.25) for every 5-year increment in oral contraceptive use. The duration of oral contraceptive use was positively associated with the risk of hypertension in this meta-analysis.
进行了一项荟萃分析,以评估口服避孕药使用时长与高血压风险之间的关联。通过检索PubMed、科学网、万方数据库和中国知网,确定截至2017年1月发表的英文或中文相关研究。本荟萃分析纳入了17篇文章,包含24项研究,共270284名参与者。口服避孕药使用时长最高类别与最低类别相比,高血压的合并相对风险为1.47(95%置信区间为1.25 - 1.73),排除三项相对风险>3.0的研究后,合并相对风险为1.26(95%置信区间为1.11 - 1.44)。发现了线性剂量反应关系(P = 0.69),口服避孕药使用每增加5年,高血压风险增加13%(相对风险为1.13;95%置信区间为1.03 - 1.25)。在本荟萃分析中,口服避孕药使用时长与高血压风险呈正相关。